These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30556755)

  • 1. Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities.
    Pession A; Lonetti A; Bertuccio S; Locatelli F; Masetti R
    Expert Opin Ther Targets; 2019 Feb; 23(2):87-91. PubMed ID: 30556755
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase?
    Khan AA; Harrison CN; McLornan DP
    Br J Haematol; 2015 Aug; 170(3):323-35. PubMed ID: 25892100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.
    Shallis RM; Bewersdorf JP; Boddu PC; Zeidan AM
    Expert Rev Anticancer Ther; 2019 Aug; 19(8):717-729. PubMed ID: 31422721
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.
    Reikvam H; Hauge M; Brenner AK; Hatfield KJ; Bruserud Ø
    Expert Rev Hematol; 2015 Jun; 8(3):299-313. PubMed ID: 25835070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [European approvals: Glasdegib for Acute myeloid leukemia].
    Barrière S; Gastaud L
    Bull Cancer; 2020 Dec; 107(12):1206-1207. PubMed ID: 33070952
    [No Abstract]   [Full Text] [Related]  

  • 6. NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia.
    Kakiuchi S; Minami Y; Miyata Y; Mizutani Y; Goto H; Kawamoto S; Yakushijin K; Kurata K; Matsuoka H; Minami H
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise.
    Bohl SR; Bullinger L; Rücker FG
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of Hedgehog inhibitors in acute myeloid leukemia and establishment of valid biomarkers].
    Minami Y
    Rinsho Ketsueki; 2019; 60(7):843-846. PubMed ID: 31391375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Key molecular mechanisms associated with cell malignant transformation in acute myeloid leukemia].
    Orlova NN; Lebedev TD; Spirin PV; Prassolov VS
    Mol Biol (Mosk); 2016; 50(3):395-405. PubMed ID: 27414778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the hedgehog pathway: role in cancer and clinical implications of its inhibition.
    Cohen DJ
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):565-88, viii. PubMed ID: 22520980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of anticancer agents targeting the Hedgehog signaling.
    Zhang X; Tian Y; Yang Y; Hao J
    Cell Mol Life Sci; 2017 Aug; 74(15):2773-2782. PubMed ID: 28314894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer.
    Jäger T; Ocker M; Kiesslich T; Neureiter E; Neureiter D
    Expert Opin Investig Drugs; 2017 Feb; 26(2):133-136. PubMed ID: 28004600
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2011 Mar; 31(3):893-6. PubMed ID: 21498710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia.
    Goemans BF; Zwaan CM; Vijverberg SJ; Loonen AH; Creutzig U; Hählen K; Reinhardt D; Gibson BE; Cloos J; Kaspers GJ
    Leukemia; 2008 Dec; 22(12):2284-5. PubMed ID: 18563175
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
    Queiroz KC; Spek CA; Peppelenbosch MP
    Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog Signaling Pathway as Genetic and Epigenetic Target in Ovarian Tumors.
    Levanat S; Sabol M; Musani V; Ozretic P; Trnski D
    Curr Pharm Des; 2017; 23(1):73-94. PubMed ID: 27719639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
    Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
    Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Hedgehog pathway in cancer.
    Rubin LL; de Sauvage FJ
    Nat Rev Drug Discov; 2006 Dec; 5(12):1026-33. PubMed ID: 17139287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.